Insulin degludec and liraglutide Subcutaneous and Xopenex Pediatric
Determining the interaction of Insulin degludec and liraglutide Subcutaneous and Xopenex Pediatric and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin degludec and liraglutide (Subcutaneous)
Generic Name: levalbuterol
Brand name: Xopenex, Xopenex Concentrate, Xopenex HFA
Synonyms: Levalbuterol inhalation, Levalbuterol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin degludec and liraglutide Subcutaneous-Xospata
- Insulin degludec and liraglutide Subcutaneous-Xoten-C
- Insulin degludec and liraglutide Subcutaneous-Xpect-AT
- Insulin degludec and liraglutide Subcutaneous-Xpect-PE
- Insulin degludec and liraglutide Subcutaneous-Xpovio
- Insulin degludec and liraglutide Subcutaneous-Xpovio (100 MG Once Weekly)
- Xopenex Pediatric-Insulin degludec Subcutaneous
- Xopenex Pediatric-Insulin detemir
- Xopenex Pediatric-Insulin Detemir (Cartridges and Prefilled Syringes)
- Xopenex Pediatric-Insulin Detemir (Vials)
- Xopenex Pediatric-Insulin detemir Subcutaneous
- Xopenex Pediatric-Insulin glargine